Tyman Regulatory News (TYMN)

TYMAN PLC

("Tyman" or the "Group")

25 January 2022

Director Declaration

In accordance with Listing Rule 9.6.14R, Tyman announces that Jo Hallas, the Group's Chief Executive Officer, will be appointed as a Non-Executive Director of Smith & Nephew plc, the global medical technology business, with effect from 1 February 2022.

Enquiries

Tyman plcPeter Ho, General Counsel & Company Secretary

020 7976 8000www.tymanplc.com

Notes to editors

Tyman (TYMN: LSE) is a leading international supplier of engineered fenestration components and access solutions to the construction industry. The company designs and manufactures products that enhance the comfort, sustainability, security, safety and aesthetics of residential homes and commercial buildings. Tyman's portfolio of leading brands serve their markets through three divisions: Tyman North America (AmesburyTruth), Tyman UK & Ireland (ERA) and Tyman International (SchlegelGiesse). Headquartered in London, the Group employs approximately 4,300 people with facilities in 16 countries worldwide. Further information is available at www.tymanplc.com.